chlorpromazine and erythromycin

chlorpromazine has been researched along with erythromycin in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (38.10)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (23.81)	29.6817
2010's	16 (38.10)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M	1
Drew, R; Piestly, BG	1
Hiller, FC; Olsen, KM	1
Amblard, P; Bastrenta, F; Beani, JC; Gautron, R; Harrouch, L; Jardon, P; Reymond, JL	1
Kendler, J; Libber, S; Lukacs, L; Zimmerman, HJ	1
Bornschein, M; Florstedt, H; Richter, B; Voigt, R	1
Edwards, WM	1
Bianchine, JR; Dujovne, CA; Lasagna, L; Lavelle, G; Weiss, P	1
Ishida, K; Suwa, K; Taguchi, I; Uehara, K; Ushio, K	1
Linares Rodríguez, A; Recarte Alvarez, J; Rodrigo Sáez, L; Valerdiz Casasola, S	1
Hewlett, EL; Myers, GA; Pearson, RD	1
Abernathy, CO; Lukacs, L; Zimmerman, HJ	1
TITOVA, AI	1
LEAU, O	1
NASSER, WK	1
ARIAS, S; NEGRETE, D; RUIZSANCHEZ, A; RUIZSANCHEZ, F	1
CORMIA, FE	1
Matsudaira, H; Searashi, Y; Takagi, I	1

Reviews

3 review(s) available for chlorpromazine and erythromycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Hepatitis caused by drugs. 5]. Revista espanola de las enfermedades del aparato digestivo, 1982, Volume: 62, Issue:5 Topics: Chemical and Drug Induced Liver Injury; Chlorpromazine; Deoxyepinephrine; Erythromycin; Gold; Humans; Hypoglycemic Agents; Oxacillin; Oxyphenisatin Acetate; Perhexiline; Phenylbutazone; Prognosis; Propylthiouracil	1982
[Drug-induced cholestasis]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antineoplastic Agents; Antipsychotic Agents; Chlorpromazine; Cholestasis; Drugs, Chinese Herbal; Erythromycin; Humans; Immunosuppressive Agents; Penicillins; Sulfamethoxazole; Testosterone Congeners; Trimethoprim	2007

Other Studies

39 other study(ies) available for chlorpromazine and erythromycin

Article	Year
Rational use of in vitro P-glycoprotein assays in drug discovery. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:2 Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera	2001
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19 Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1 Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics	2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium. European journal of medicinal chemistry, 2017, Nov-10, Volume: 140 Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones	2017
Effect of chlorpromazine and erythromycin on bile salt-induced cholestasis in the rat. Pharmacology, 1979, Volume: 18, Issue:4 Topics: Alanine Transaminase; Animals; Bile; Chlorpromazine; Cholestasis; Drug Interactions; Erythromycin; Erythromycin Estolate; Humans; Male; Nucleotidases; Rats; Taurochenodeoxycholic Acid; Taurolithocholic Acid	1979
Management of tetanus. Clinical pharmacy, 1987, Volume: 6, Issue:7 Topics: Aged; Aged, 80 and over; Chlorpromazine; Clostridium tetani; Darkness; Diazepam; Erythromycin; Female; Humans; Intensive Care Units; Middle Aged; Morphine; Ranitidine; Tetanus; Tetanus Toxoid	1987
Screening for drug photosensitization activity by measuring the variations in oxygen consumption of Bacillus subtilis. Photo-dermatology, 1985, Volume: 2, Issue:2 Topics: Aspirin; Bacillus subtilis; Benzoyl Peroxide; Chlorpromazine; Erythromycin; Fluorouracil; Light; Methoxsalen; Oxygen Consumption; Patch Tests; Photosensitivity Disorders; Tretinoin	1985
Hepatocyte suspensions as a model for demonstration of drug hepatotoxicity. Biochemical pharmacology, 1974, Volume: 23, Issue:15 Topics: Animals; Aspartate Aminotransferases; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chlorpromazine; Erythromycin; In Vitro Techniques; Liver; Models, Biological; Osmolar Concentration; Rats	1974
[Effect of surface-active substances on artificial (hydrophilic) membranes]. Die Pharmazie, 1972, Volume: 27, Issue:9 Topics: Biopharmaceutics; Cellulose; Chlorpromazine; Dialysis; Erythromycin; Membranes, Artificial; Methods; Nitrates; Rifamycins; Sodium; Sodium Dodecyl Sulfate; Surface-Active Agents	1972
[Tetanus neonatorum]. Monatsschrift fur Kinderheilkunde, 1970, Volume: 118, Issue:6 Topics: Amobarbital; Anti-Bacterial Agents; Chloral Hydrate; Chlorpromazine; Erythromycin; Humans; Hypnotics and Sedatives; Infant, Newborn; Infant, Newborn, Diseases; Penicillins; Prognosis; Streptomycin; Tetanus; Tetanus Antitoxin	1970
Toxicity of hepatotoxic drugs on mouse liver tissue culture. Archives internationales de pharmacodynamie et de therapie, 1970, Volume: 186, Issue:1 Topics: Animals; Chlorpromazine; Culture Techniques; Erythromycin; Glucuronidase; L-Lactate Dehydrogenase; Liver; Malate Dehydrogenase; Mice; Promazine	1970
[6 recent cases of toxic hepatitis]. Naika. Internal medicine, 1966, Volume: 18, Issue:2 Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Chlorpromazine; Erythromycin; Female; Humans; Male; Middle Aged; Novobiocin; Phosphorus; Porphyrias	1966
Susceptibility of Bordetella species to growth inhibition and killing by chlorpromazine. Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:2 Topics: Adenylyl Cyclase Inhibitors; Bordetella; Chlorpromazine; Erythromycin; Microbial Sensitivity Tests	1983
Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note. Mechanisms of ageing and development, 1980, Volume: 12, Issue:1 Topics: Aging; Animals; Aspartate Aminotransferases; Cell Extracts; Chlorpromazine; Erythromycin; Erythromycin Estolate; In Vitro Techniques; Liver; Male; Rats	1980
[APROPOS OF PREVENTION AND TREATMENT OF PNEUMONIA IN YOUNG CHILDREN]. Pediatriia, 1963, Volume: 42 Topics: Anti-Bacterial Agents; Child; Chlorpromazine; Erythromycin; gamma-Globulins; Infant; Infant, Newborn; Oxytetracycline; Penicillins; Pneumococcal Infections; Pneumonia; Pneumonia, Viral; Staphylococcal Infections; Streptomycin; Tetracycline	1963
[RELATION BETWEEN BLOOD CONCENTRATION AND THERAPEUTIC ACTION]. La Presse medicale, 1963, Oct-12, Volume: 71 Topics: Amidines; Anti-Bacterial Agents; Blood Chemical Analysis; Chlorpromazine; Chlorprothixene; Drug Therapy; Erythromycin; Imipramine; Oleandomycin; Penicillins; Promazine; Promethazine; Quinolines; Spiramycin; Stilbamidines; Suramin; Tetracycline; Tranquilizing Agents	1963
CLINICAL TETANUS: TREATMENT OF TEN CASES. The Journal of the Indiana State Medical Association, 1964, Volume: 57 Topics: Chlorpromazine; Debridement; Desensitization, Immunologic; Erythromycin; Humans; Injections; Injections, Intramuscular; Mephenesin; Meprobamate; Nursing; Parenteral Nutrition; Penicillins; Secobarbital; Tetanus; Tetanus Antitoxin; Tetanus Toxoid; Tracheotomy	1964
[BENZODIAZEPINE AS A COADJUVANT IN THE TREATMENT OF TETANUS]. Medicina, 1964, Aug-25, Volume: 44 Topics: Anti-Bacterial Agents; Benzodiazepines; Chlorpromazine; Diazepam; Drug Therapy; Erythromycin; Humans; Meprobamate; Penicillins; Promethazine; Protein Synthesis Inhibitors; Tetanus; Tetanus Toxoid; Tetracycline	1964
POTENTIATION OF HYPERPIGMENTATION FROM X-RADIATION. EFFECTS OF DEMETHYLCHLORTETRACYCLINE THERAPY. Archives of dermatology, 1964, Volume: 90 Topics: Acne Vulgaris; Chlorpromazine; Demeclocycline; Drug Therapy; Erythromycin; Facial Dermatoses; Humans; Hyperpigmentation; Pigmentation Disorders; Radiation Effects; Radiotherapy; X-Rays	1964